ImmunityBio Gets FDA Authorisation For Phase 1 Human Study Of NK Cell Platform With IL-15 Anktiva

ImmunityBio, Inc. (IBRX) Monday said has received FDA authorization to conduct a Phase 1 human study of its Memory Cytokine-Enriched NK cell platform combined with its IL-15 superagonist Anktiva in subjects with locally advanced or metastatic solid tumors.

The clinical-stage immunotherapy company announced that its autologous and allogeneic cryopreserved memory NK cells have the ability to recognize and kill cancer targets with increased production of interferon-g, a cytokine demonstrating high activity.

Further, the company noted that the combination of these tools has the potential to place ImmunityBio in a leading position to activate the patient's immune system in the fight against cancer across both solid and liquid tumors.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Velvet Ice Cream recalled certain lots of its 56 oz Raspberry Fudge Cordial Ice Cream for potentially containing undeclared peanuts, the U.S. Food and Drug Administration or FDA said in a statement. The recall was initiated after it was notified of the issue by a single customer and has since learned that the cause of the error has been traced to a third-party manufacturer packaging error. Willard, Ohio-based Buurma Farms Inc. is recalling 320 boxes of its Plain Parsley citing possible contamination with Shiga-toxin producing E.coli, the U.S. Food and Drug Administration said. The recall involves Buurma Plain (flat leaf) Parsley with a harvest date of August 30, 2021 from their Gregory, Michigan location. Molson Coors Beverage Co. is bringing Topo Chico Hard Seltzer, the sparkling mineral water, across the United States starting January 2022. The company will officially expand the distribution of the product, which was launched last spring in nine states and seven metro areas, to all 50 states. Molson Coors is manufacturing, marketing and distributing Topo Chico Hard Seltzer in the U.S.
Follow RTT